About
We allow biomedical researchers to
detect what was previously undetectable
Innovation in Detection
Drives New Discovery
Hubble Space Telescope
James Webb Space Telescope
Discover The Universe Inside Your Body
New biomedical discovery is driving the need to find improved methods to detect novel and rare biomarkers. Early cancer detection, drug discovery, mRNA vaccines, immunology all rely on accurate detection of rare biomarkers and measurement of many biomarkers at the same time.
Our vision is to improve detection with a drop-in technology that allows dyes and current instruments to reach their full potential and unlock a new wave of biomedical innovation. Today our team is making this a reality at two locations in Ann Arbor and Houghton, home of Michigan Technological University.
StabiLux® Bright Technology™ offers biomedical researchers a product platform, which can help discover new biomarkers, detect those in blood samples and monitor treatment effectiveness in the clinic.
New biomedical discovery is driving the need to find improved methods to detect novel and rare biomarkers. Early cancer detection, drug discovery, mRNA vaccines, immunology all rely on accurate detection of rare biomarkers and measurement of many biomarkers at the same time.
Our vision is to improve detection with a drop-in technology that allows dyes and current instruments to reach their full potential and unlock a new wave of biomedical innovation. Today our team is making this a reality in both Ann Arbor and Houghton, Michigan – home of Michigan Technological University.
StabiLux® Bright Technology™ offers biomedical researchers a product platform, which can discover new biomarkers, detect those biomarkers in blood samples and monitor treatment efficacy in the clinic.
The team making it happen
CEO
President
Principle Scientist
Advisors
Chemical Physics
Microbiology & Immunology
VP of Operations